Q16595 AF NFT

Frataxin, mitochondrial

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiemoi6jn2gfewx7ekksr74csfymd6gy3ncafnhh76og5sguwkldru/metadata.json
IPFS of structure file: 
bafybeideczy77qxjbcxqf6kidcywh7ecgzoljqtgnmyyr3gu643nixzuc4/AF-Q16595-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xd6dAC69607350B6653b5aBcE7c26e6D0Da978570
First NFT owner address (bech32): 
genesis16mdvd9s8x59kv5a44088cfhx6rdf0pts9ha0pc
Current NFT ID #135864 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
135864
Accession (UniProt):
Q16595
Name::
Frataxin, mitochondrial
Experimental Method:
Predicted structure
Sequence source:
HOMO SAPIENS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q16595 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q16595|FRDA_HUMAN Frataxin, mitochondrial OS=Homo sapiens OX=9606 GN=FXN PE=1 SV=2 MWTLGRRAVAGLLASPSPAQAQTLTRVPRPAELAPLCGRRGLRTDIDATCTPRRASSNQRGLNQIWNVKKQSVYLMNLRKSGTLGHPGSLDETTYERLAEETLDSLAEFFEDLADKPYTFEDYDVSFGSGVLTVKLGGDLGTYVINKQTPNKQIWLSSPSSGPKRYDWTGKNWVYSHDGVSLHELLAAELTKALKTKLDLSSLAYSGKDA